Reply to Kowa et al.: Variant-specific treatment gaps: Evaluating the low use of tocilizumab and enoxaparin in omicron ICU cases

J Formos Med Assoc. 2024 Dec 30:S0929-6646(24)00611-9. doi: 10.1016/j.jfma.2024.12.032. Online ahead of print.
No abstract available

Publication types

  • Letter